MT
MyopiaTracker Clinical Team
Reviewed by Dr. Balamurali Vasudevan, BSOptom, PhD, FAAO, MBA · Last updated: April 2026

When Does Myopia Stop Progressing?
What Actually Determines Stabilisation

Short answer: For most people, myopia progression slows significantly through the mid-teens and stabilises somewhere in the late teens to early 20s. But there's no fixed age — it depends on when myopia started, how fast it has been progressing, and genetic factors.

18–21
Typical age range when most myopia stabilises in the general population (European cohorts)
25%
Of myopes continue progressing beyond age 24, particularly those with high myopia (>−6D)
Earlier
Onset of myopia = later stabilisation and higher final prescription — earlier start means more years of growth

The natural progression timeline

Eye growth follows a predictable but individual trajectory. In most children, the eye grows fastest between ages 7 and 12 — the period of fastest overall bodily growth. After puberty, the rate of axial elongation slows progressively. By the late teens, most people's eye growth has decelerated to a clinically insignificant rate.

This deceleration is why myopia management has the most impact in younger children: the treatment period coincides with the fastest growth phase.

Factors that influence stabilisation age

Age of onset

Children who become myopic at age 6–7 tend to progress for longer and reach higher final prescriptions than children who become myopic at age 12–13. Early-onset myopia has more years of the fastest growth phase ahead of it. A child myopic at age 7 may not stabilise until 21–22, while one who starts at 13 may stabilise by 18–19.

Rate of progression

Fast progressors typically continue progressing for longer and reach higher final prescriptions. The trajectory does not usually reverse — a child growing at 0.40mm/year in childhood tends to have higher-than-average adult axial length even after progression slows.

Ethnicity and genetics

East Asian populations tend to show higher final prescriptions and may stabilise later on average compared to European populations, based on cohort data. Genetic loading (both parents myopic) is associated with higher final prescriptions regardless of ethnicity.

Does myopia ever start in adulthood?

Yes — adult-onset myopia (typically defined as onset after age 18) does occur, usually in the range of −1 to −3D, often triggered by sustained near work (university study, office work). This is generally slower-progressing and reaches lower final prescriptions than childhood-onset myopia.

After stabilisation: what still matters

Once myopia has stabilised, the prescription is fixed — but the structural risks associated with the axial length remain throughout life. A 35-year-old with a stable −7D myopia from childhood still has the same elevated retinal risk as when they were 18. Annual dilated eye examinations and awareness of retinal detachment symptoms remain important regardless of whether the prescription is changing.

Track whether your child's myopia is slowing

Enter axial length measurements from multiple visits to see the progression rate trend and whether it's decelerating as expected.

Track progression →

Free · No login · Under 30 seconds

Sources: Tideman JWL et al. Acta Ophthalmologica. 2018;96(3):301–309 · Flitcroft DI. Prog Retin Eye Res. 2012;31(6):622–660 · Donovan L et al. Ophthalmic Physiol Opt. 2012;32(3):240–247

This page is for educational purposes and does not constitute medical advice. MyopiaTracker is a decision-support tool — not a diagnostic device. MiSight® is a registered trademark of The Cooper Companies. Stellest® is a registered trademark of Essilor International. MiyoSmart® is a registered trademark of Hoya Corporation. Treatment availability and regulatory approval vary by country. Consult a qualified optometrist or ophthalmologist for personalised advice.

About the reviewer: Dr. Balamurali Vasudevan (BSOptom, PhD, FAAO, MBA) is an Associate Professor and Vision Science Lead at Midwestern University, AZ, with 54+ peer-reviewed publications and 20+ years in clinical vision science and myopia research. Former Senior Clinical Vision Scientist at Johnson & Johnson Vision Care. All clinical content on MyopiaTracker is reviewed for accuracy against primary literature before publication.
Related Resources
Progression rates by age → Long-term risk if myopia is high → Slow it down — treatment options → Project final prescription →